← Back to Search

Blood Collection Device

TAP20-C for Diabetes

N/A
Waitlist Available
Research Sponsored by Seventh Sense Biosystems
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1
Awards & highlights

Study Summary

This study will compare blood collection from the forearm using an investigational device TAP20-C to blood collection from the fingertip.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Non-Inferiority of Analyte Levels

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: TAP20-CExperimental Treatment1 Intervention
TAP20-C
Group II: FingerstickActive Control1 Intervention
Fingerstick

Find a Location

Who is running the clinical trial?

Seventh Sense BiosystemsLead Sponsor
2 Previous Clinical Trials
2 Trials studying Diabetes

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~12 spots leftby Apr 2025